del-Río Camacho G, Martínez González M, Sanabria Brossart J, Gutiérrez Moreno E, Gómez García T, Troncoso Acevedo F
Servicio de Pediatría, Unidad Multidisciplinar del Sueño, Fundación Jiménez Díaz, Madrid, España.
Servicio de Pediatría, Unidad Multidisciplinar del Sueño, Fundación Jiménez Díaz, Madrid, España.
Acta Otorrinolaringol Esp. 2014 Sep-Oct;65(5):302-7. doi: 10.1016/j.otorri.2014.03.004. Epub 2014 Jun 2.
In recent years, with the rise of sleep-disordered breathing, we have been seeing more articles related to post-operative complications after adenotonsillectomy in children with sleep apnea-hypopnea syndrome (OSAS), especially in those with severe sleep apnea. The objective of this study was to evaluate post-operative complications in children with severe OSAS compared to children who had adenotonsillectomy for a different reason, and establish whether they needed admission to an intensive care unit or not.
All children undergoing adenotonsillectomy in our hospital in the last 5 years were initially included in this study. Complications were analysed with a retrospective review.
Two hundred and twenty nine children admitted for adenotonsillectomy were finally included. In the whole group, complications occurred in 3.5% of children, 2.2% corresponding to respiratory complications. Children with sleep apnea (3.23% vs 1.47%, P=.39) or severe sleep apnea (3.77% vs 1.70%, P=.32) presented a higher incidence of respiratory complications, which was not statistically significant and was far below those published by other authors. All respiratory complications took place in the immediate post-operative period (operating theatre or anaesthesia recovery), with none in the paediatric ward.
In our population, children who undergo adenotonsillectomy, without any other comorbidities, malformation syndrome or neuromuscular disease, are more than 2 years old and have an immediate postoperative period without incidence, do not need to be systematically admitted to an intensive care unit, even if they present with severe OSAS.
近年来,随着睡眠呼吸障碍的增多,我们看到了更多与睡眠呼吸暂停低通气综合征(OSAS)患儿扁桃体腺样体切除术后并发症相关的文章,尤其是重度睡眠呼吸暂停患儿。本研究的目的是评估重度OSAS患儿与因其他原因行扁桃体腺样体切除术的患儿相比的术后并发症,并确定他们是否需要入住重症监护病房。
最初纳入了我院过去5年中所有接受扁桃体腺样体切除术的患儿。通过回顾性分析对并发症进行分析。
最终纳入了229例因扁桃体腺样体切除术入院的患儿。在整个队列中,3.5%的患儿出现并发症,2.2%为呼吸系统并发症。睡眠呼吸暂停患儿(3.23%对1.47%,P = 0.39)或重度睡眠呼吸暂停患儿(3.77%对1.70%,P = 0.32)呼吸系统并发症发生率更高,但差异无统计学意义,且远低于其他作者发表的数据。所有呼吸系统并发症均发生在术后即刻(手术室或麻醉恢复室),儿科病房无并发症发生。
在我们的研究人群中,接受扁桃体腺样体切除术、无其他合并症、畸形综合征或神经肌肉疾病、年龄超过2岁且术后即刻无并发症发生的患儿,即使患有重度OSAS,也无需常规入住重症监护病房。